Your session is about to expire
← Back to Search
Other
No dx of alcohol use disorder, panic or depre for HIV (ARCH-IRA Trial)
Phase 4
Waitlist Available
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up between baseline and 6 month follow-up
Awards & highlights
ARCH-IRA Trial Summary
This trial will examine the effects of an algorithm-based treatment for alcoholism on alcohol consumption, retention in HIV care, and HIV-related outcomes.
Eligible Conditions
- HIV
- Alcoholism
ARCH-IRA Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ between baseline and 6 month follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~between baseline and 6 month follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Self-reported change in alcohol use
Secondary outcome measures
PEth levels
ARCH-IRA Trial Design
3Treatment groups
Active Control
Group I: No dx of alcohol use disorder, panic or depreActive Control1 Intervention
Computerized Brief Intervention (CBI)- a video about alcohol abuse
Group II: Risky drinking, no dx of AUD, has panic or depressionActive Control2 Interventions
Computerized Brief Intervention (CBI)- a video about alcohol abuse, plus 4 sessions of counseling called Motivational Enhancement Therapy
Group III: Dx of AUD with or without panic or depressionActive Control3 Interventions
Computerized Brief Intervention (CBI)- a video about alcohol abuse, plus 4 sessions of counseling called Motivational Enhancement Therapy plus a recommendation for Alcohol Pharmacotherapy (APT). The drugs recommended in the APT are all standard of care drugs for alcohol treatment and are not under study in this protocol.
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,589 Previous Clinical Trials
2,280,196 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger